| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/25/2009 | CN101374820A Piperazine compounds with a herbicidal action |
| 02/25/2009 | CN101374815A Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN101372486A Preparation of abafungin and analogues thereof |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7495016 inhibiting HIV replication in a cell; inhibiting reverse transcriptase |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7494998 Benzisoxazole piperazine compounds and methods of use thereof |
| 02/24/2009 | US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2224438C Vinyl-pyrrolidinone cephalosporins with basic substituents |
| 02/19/2009 | WO2009023752A1 Adrenergic compounds |
| 02/19/2009 | WO2009023655A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists |
| 02/19/2009 | WO2009022171A1 Pyridinyiioxy pyridines as alk5 inhibitors |
| 02/19/2009 | WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 02/19/2009 | WO2008154246A8 Hiv integrase inhibitors |
| 02/19/2009 | WO2008087514A3 Hdac inhibitors |
| 02/19/2009 | WO2008079787A3 Glucokinase activators |
| 02/19/2009 | US20090048443 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/19/2009 | US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048282 Pyrimidine sulfonamide analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048112 Novel Herbicides |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047354 process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047247 Pyrrolidine Derivatives |
| 02/19/2009 | US20090047244 Macrocyclic serine protease inhibitors i |
| 02/19/2009 | DE102007038957A1 6-Thioxo-pyridazinderivate 6-thioxo-pyridazine derivatives |
| 02/19/2009 | CA2696430A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | CA2696314A1 Therapeutic compounds |
| 02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
| 02/19/2009 | CA2685605A1 Treatment of duchenne muscular dystrophy |
| 02/18/2009 | EP2024364A1 Heterocyclic compounds as calcium channel blockers |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024349A2 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 02/18/2009 | EP1888576B1 Process for making aztreonam |
| 02/18/2009 | EP1732903B1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 02/18/2009 | EP1723143B1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 02/18/2009 | EP1603886B1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370796A Thiazoles as 11 beta-HSD1 inhibitors |
| 02/18/2009 | CN101370786A Substituted imidazoles and their use as pesticides |
| 02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |
| 02/18/2009 | CN100462363C Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462068C Alphavbeta3 and alphavbeta6 integrin antagonists as antifibrotic agents |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491821 2-(4-fluorophenyl)-4-propyl-oxazole-5-carboxylic acid {2-[4-(6-aminopyridin-2-yl)-piperazin-1-yl]-1-methyl-ethyl}amide; purinergic receptor antagonists, analgesics; urogenital, gastointestinal and respiratory system disorders |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491737 Heterarylpiperidine modulators of chemokine receptor activity |
| 02/17/2009 | US7491735 e.g. N-(3-{4-[(4-Bromo-phenyl)-(3-chloro-benzyl)-amino]-piperidin-1-yl}-butyl)-3,5-dichloro-isonicotinamide; viricide, antiinflammation agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV) |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491725 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 02/17/2009 | US7491713 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2009 | WO2009020579A1 Gamma secretase modulators |
| 02/12/2009 | WO2009020470A2 Cgrp receptor antagonists |
| 02/12/2009 | WO2009020191A1 Tetrazoyloxime derivative and plant disease control agent |
| 02/12/2009 | WO2009019202A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/12/2009 | WO2009018844A1 Thiazole-piperidine derivatives for treatment of hyperproliferative diseases |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2008152073A3 Piperazine compounds with a herbicidal action |
| 02/12/2009 | WO2008139481A3 Proton acceptor iminium/carbocation-type coupling agents |
| 02/12/2009 | WO2008127349A3 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 02/12/2009 | WO2008119563A3 Method for producing epothilone derivatives by means of selective catalytic epoxidation |
| 02/12/2009 | WO2007134169A3 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043103 Organic dye used in dye-sensitized solar cell |
| 02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
| 02/12/2009 | US20090042918 Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 |
| 02/12/2009 | US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 02/12/2009 | US20090041723 useful in the production of a library of pyrazole derivatives for biological screening; Hepatitis C virus (HCV); ease of crystallization, yield, stability, solubility, hygroscopicity and flowability of the resulting bulk drug |
| 02/12/2009 | US20090041720 Heteroaryl substituted thiazoles |